Caroline was appointed Academic Director for Cambridge-Africa in October 2018, succeeding Professor David Dunne (the founding Director in 2008). She is a Principal Research Associate in Epidemiology at the University of Cambridge and an honorary epidemiologist at UK Health Security Agency. Her research examines the potential and actual impact of immunisation using a range of methods from classic epidemiology to mathematical modelling and health economics. Her work has been used to inform national and (as a consultant to the World Health Organisation) international vaccine policy. Much of Caroline's research is focussed on meningococcal disease and carriage in the UK and Africa, working with African partners, including the African Meningococcal Carriage Consortium (MenAfriCar). She has been involved in a range of projects in the African meningitis belt, both to quantify the impact of MenAfriVac (an affordable group A meningococcal conjugate vaccine), and to investigate both short (epidemic response) and long-term (preventive vaccination) options for the control of epidemic meningitis. She also has current projects on the impact of vaccination against group B streptococcus and rabies. She is also a fellow of Hughes Hall in Cambridge. Read more about Caroline’s vaccine work at http://www.iph.cam.ac.uk/public-health-policy/case-studies/shaping-vaccination-guidelines.

Email: clt56@cam.ac.uk  Tel: +44 (0) 1223 765631

Corinna re-joined Cambridge-Africa in January 2023 having been the THRiVE and MUII coordinator from 2016-2021. Corinna worked closely with THRiVE and MUII partners and Fellows based in Uganda, Tanzania and Kenya. Corinna established remote seminar series on immunology and bioinformatics to assist new Masters courses at Makerere University, Uganda and initiated a new collaboration between the Uganda Cancer Institute and a range of partners in Cambridge.

Corinna’s career has focused on public health. Between 2021- 2023 Corinna worked in Cambridge’s Department of Medicine as a Project manager on the THECA programme - a ‘real world’ clinical trial conducted with Congolese colleagues assessing the impact of a new Typhoid (TCV) vaccine being trialled in DRC and other parts of Africa. Corinna worked for 10 years at the PHG Foundation where her work focused on the incorporation of genetics into health care as genetics increasingly transformed medical and public health practice.  Previously Corinna worked as a research associate at Manchester University, as a team leader in the North West Regional Health Authority developing primary care and as a senior health promotion officer in Central Manchester. Corinna’s interest in working with African colleagues on African health priorities was sparked by working as a secondary school teacher in Kenya.

Email: ca392@cam.ac.uk

Kess joined the Cambridge-Africa team as a Research Coordinator in September 2022. She completed a BSc in Biochemistry and Microbiology from the University of Sheffield in 2021, as well as an MSc in Control of Infectious Disease from the London School of Hygiene and Tropical Medicine in 2022. She is also a Head Editor for the public health magazine Keppel Health Review (Keppel Health Review). She is interested in capacity building for pandemic preparedness, particularly in the context of equitable vaccine distribution and genomic surveillance.

Email: ktr23@cam.ac.uk